Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of High Intensity Focused Ultrasound (HIFU) Device to Treat Uncontrolled Secondary Hyperparathyroidism in Chronic Haemodialysis Patients

NCT01421407 is registered in ClinicalTrials.gov with Theraclion as lead sponsor.

NCT NCT01421407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01421407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of High Intensity Focused Ultrasound (HIFU) Device to Treat Uncontrolled Secondary Hyperparathyroidism in Chronic Haemodialysis Patients
Lead sponsor
Theraclion
Phase
Not applicable
Overall status
Withdrawn
Start date
August 31, 2011
Completion date
January 31, 2014
Enrollment
0 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease, parathyroid hyperplasia, secondary hyperparathyroidism